Skip to Content

Journal of Clinical Medicine, Volume 4, Issue 6

2015 June - 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (11)

  • Review
  • Open Access
62 Citations
13,804 Views
23 Pages

Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade

  • Maria Vanessa Perez-Gomez,
  • Maria Dolores Sanchez-Niño,
  • Ana Belen Sanz,
  • Catalina Martín-Cleary,
  • Marta Ruiz-Ortega,
  • Jesus Egido,
  • Juan F. Navarro-González,
  • Alberto Ortiz and
  • Beatriz Fernandez-Fernandez

18 June 2015

Diabetic kidney disease is the most frequent cause of end-stage renal disease. This implies failure of current therapeutic approaches based on renin-angiotensin system (RAS) blockade. Recent phase 3 clinical trials of paricalcitol in early diabetic k...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Review
  • Open Access
27 Citations
10,778 Views
19 Pages

Role of Neuropilin-1 in Diabetic Nephropathy

  • Tzvetanka Bondeva and
  • Gunter Wolf

17 June 2015

Diabetic nephropathy (DN) often develops in patients suffering from type 1 or type 2 diabetes mellitus. DN is characterized by renal injury resulting in proteinuria. Neuropilin-1 (NRP-1) is a single-pass transmembrane receptor protein devoid of enzym...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Article
  • Open Access
2 Citations
6,296 Views
13 Pages

17 June 2015

The objective of the study was to identify all parallel design randomised controlled trials (RCTs) comparing treatments for eczema in recent dermatology literature that have failed to report a between-group analysis. The GREAT database (www.greatdata...

(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
  • Article
  • Open Access
8 Citations
5,593 Views
12 Pages

Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy

  • Balneek Singh Cheema,
  • Sreenivasa Iyengar,
  • Rajni Sharma,
  • Harbir Singh Kohli,
  • Anil Bhansali and
  • Madhu Khullar

10 June 2015

Background: Osteopontin (OPN) C-443T promoter polymorphism has been shown as a genetic risk factor for diabetic nephropathy (DN) in type 2 diabetic patients (T2D). Methods: In the present study we investigated the association of three functional prom...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Review
  • Open Access
9 Citations
6,515 Views
29 Pages

Alternative Donor Transplantation for Acute Myeloid Leukemia

  • Nelli Bejanyan,
  • Housam Haddad and
  • Claudio Brunstein

9 June 2015

Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for adult patients with acute myeloid leukemia (AML), but its use for consolidation therapy after first remission with induction chemotherapy used to be limite...

(This article belongs to the Special Issue AML in the Molecular Age: From Biology to Clinical Management)
  • Review
  • Open Access
15 Citations
9,203 Views
12 Pages

Kidney Transplantation in the Diabetic Patient

  • María José Pérez-Sáez and
  • Julio Pascual

9 June 2015

Diabetes mellitus is one of the most important causes of chronic kidney disease (CKD). In patients with advanced diabetic kidney disease, kidney transplantation (KT) with or without a pancreas transplant is the treatment of choice. We aimed to review...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Review
  • Open Access
103 Citations
10,049 Views
11 Pages

Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients

  • Ramya Chockalingam,
  • Christopher Downing and
  • Stephen K. Tyring

3 June 2015

Non-melanoma skin cancers represent a major cause of morbidity after organ transplantation. Squamous cell carcinomas (SCC) are the most common cutaneous malignancies seen in this population, with a 65–100 fold greater incidence in organ transplant r...

(This article belongs to the Special Issue Clinical Advances of Human Papillomaviruses)
  • Review
  • Open Access
154 Citations
29,623 Views
12 Pages

The Role of Malassezia spp. in Atopic Dermatitis

  • Martin Glatz,
  • Philipp P. Bosshard,
  • Wolfram Hoetzenecker and
  • Peter Schmid-Grendelmeier

29 May 2015

Malassezia spp. is a genus of lipophilic yeasts and comprises the most common fungi on healthy human skin. Despite its role as a commensal on healthy human skin, Malassezia spp. is attributed a pathogenic role in atopic dermatitis. The mechanisms by...

(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
  • Review
  • Open Access
15 Citations
7,087 Views
14 Pages

The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases

  • Meilyn Hew,
  • Kevin O'Connor,
  • Michael J. Edel and
  • Michaela Lucas

28 May 2015

The ability to generate inducible pluripotent stem cells (iPSCs) and the potential for their use in treatment of human disease is of immense interest. Autoimmune diseases, with their limited treatment choices are a potential target for the clinical a...

(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
  • Review
  • Open Access
134 Citations
21,534 Views
10 Pages

The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years

  • Alberto Martínez-Castelao,
  • Juan F. Navarro-González,
  • José Luis Górriz and
  • Fernando De Alvaro

28 May 2015

Diabetes Mellitus (DM) is a growing worldwide epidemic. It was estimated that more than 366 million people would be affected. DM has spread its presence over the world due to lifestyle changes, increasing obesity and ethnicities, among others. Diabet...

(This article belongs to the Special Issue Diabetic Nephropathy)
  • Review
  • Open Access
46 Citations
13,060 Views
22 Pages

Endothelin Blockade in Diabetic Kidney Disease

  • Lidia Anguiano,
  • Marta Riera,
  • Julio Pascual and
  • María José Soler

25 May 2015

Diabetic kidney disease (DKD) remains the most common cause of chronic kidney disease and multiple therapeutic agents, primarily targeted at the renin-angiotensin system, have been assessed. Their only partial effectiveness in slowing down progressio...

(This article belongs to the Special Issue Diabetic Nephropathy)
XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383